Neogen Corp SEC filings NEOG
Neogen Corp has 1,000 filings in SEC EDGAR's recent list, going back to Nov 12, 2013. Its latest annual report, Form ARS, was filed on Aug 21, 2026 for the period ended May 31, 2026. The latest quarterly report (Form 10-Q) was filed on Oct 7, 2026, covering the quarter ended Aug 31, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (other events). The company's fiscal year ends on May 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Oct 20, 2026 | — |
| S-8 | Employee stock plan registration | Oct 20, 2026 | — |
| S-8 | Employee stock plan registration | Aug 20, 2024 | — |
| S-8 | Employee stock plan registration | Aug 20, 2024 | — |
| 424B3 | Prospectus | Aug 4, 2022 | — |
| S-4/A | Filing | Aug 4, 2022 | — |
| S-4/A | Filing | Jul 27, 2022 | — |
| S-4/A | Filing | Jul 1, 2022 | — |
| S-4/A | Filing | Jun 8, 2022 | — |
| S-4/A | Filing | May 5, 2022 | — |
| S-4 | Registration for a merger or exchange | Mar 17, 2022 | — |
| S-8 | Employee stock plan registration | Jan 3, 2019 | — |
Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- In Vitro & In Vivo Diagnostic Substances (SIC 2835)
- Listed as
- NEOG (Nasdaq)
- Fiscal year ends
- May 31
- Incorporated in
- MI
- Headquarters
- Lansing, MI
- SEC filer status
- Large accelerated filer
- SEC CIK
- 711377
Other In Vitro & In Vivo Diagnostic Substances companies
- Idexx Laboratories Inc /DE IDXX
- Lantheus Holdings, Inc. LNTH
- Celldex Therapeutics, Inc. CLDX
- Intellia Therapeutics, Inc. NTLA
- QuidelOrtho Corp QDEL
- Achieve Life Sciences, Inc. ACHV
- Myriad Genetics Inc MYGN
- Alpha Teknova, Inc. TKNO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.